News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
The Penn Institute for RNA Innovation is a new institute dedicated to the understanding and development of all aspects of RNA from basic to translational science.
SchoolSims is an education company that offers technology-enhanced immersive learning solutions to leadership development for educational and other organizations.
Penn Health-Tech is well known for turning innovative ideas across the health system into useful technologies and products that solve problems and advance health care.
Pending regulatory approval, Verismo plans to use the drug in patients with mesothelin-expressing ovarian cancer, mesothelioma and cholangiocarcinoma.
iEcure is developing the new drug candidate, GTP-506, as a treatment for a rare genetic condition caused by a genetic defect in a liver enzyme responsible for detoxification of ammonia.
Our PCI Fellows graduates are thriving in careers in IP law, mechanical engineering, life sciences investment, and more.
Philadelphia's innovation hub has seen explosive growth over the past several years, with significant expansions in manufacturing and research space for multiple companies.
In this Science Friday interview, Dr. Carl June discusses CAR-T's continued use in battling new blood cancers, as well as its future potential for treating solid state cancers and autoimmune diseases.
A new 90-second video animation created by the Chamber of Commerce for Greater Philadelphia’s CEO Council for Growth shows the Philadelphia region's gene and cell therapy family tree.
A proof-of-concept study has shown that these microrobots can also access the difficult-to-reach surfaces of the root canal with controlled precision.